From November 6 to 8, 2025, the 2025 Pet Industry Technology Innovation & Investment Financing Forum themed “Intelligence Gathers Beijing Splendor・Pet Industry Thrives in Daxing” was successfully held in Beijing. Wang Zhenjun, Chief Expert of Large Model Industry Development at Huawei Strategic Research Institute and Head of Policy & Alliance Group of Huawei’s Artificial Intelligence Ecosystem & Industry Development Committee, delivered a keynote speech titled “AI Large Models Empower the Pet Industry: Trends & Opportunities”, deeply analyzing the integration path of AI technology and the pet industry, and bringing practical new inspirations for the pet industry upgrade.
Currently, AI large model technology is rapidly iterating from single - point applications to comprehensive generative services. Compared with the Internet era, its ability to restructure industries and the depth of its impact have achieved a qualitative leap. The core pain point of AI technology empowering traditional industries lies in the scarcity of cross - field compound talents. As an emerging track, the pet industry not only needs in - depth industry mechanism cognition and Know - how accumulation, but also requires the support of cutting - edge AI technology. The in - depth integration of the two is the key to industrial upgrading.
1. Pet Medical Breakthrough: End - to - end AI Solutions Fill Professional Gaps
End - to - end intelligent solutions can address the pain points in the pet medical field. The entire chain of pet medical care, including pre - triage, in - consultation, and post - consultation, as well as all links such as drug R & D, production, supply chain, sales, and service, can achieve efficiency improvement and service upgrading through AI large models.
For example, to solve the imbalance between supply and demand of specialized pet doctors, we can learn from the experience of ophthalmology large models in human medical care to build a pet disease primary consultation platform and a digital human service system. By using multi - modal technology, early screening, intelligent triage, and medical record generation can be realized, breaking the constraints of time and region and filling the gap in professional services. This model has been verified in the human medical field. Grass - roots nurses can complete full - dimensional ophthalmic screening with professional equipment and AI models, greatly improving the diagnosis and treatment efficiency and coverage. Its core logic is fully applicable to pet medical scenarios.
2. Pharmaceutical R & D Innovation: AI Large Models Address the “10 Years, 1 Billion USD” Pain Point
In the field of pet drug R & D, AI technology has subversive value. Traditional drug R & D is faced with the industry pain points of long cycle and high cost (10 years and 1 billion USD). However, AI large models can provide technical support in key links such as target discovery, hit compound optimization, and lead compound screening, and have unique advantages in cutting - edge directions such as unsteady drug - molecule binding prediction.
Huawei has built a drug large model with leading data volume and parameter scale in the industry, which can provide underlying architecture support for the personalized customized R & D of pet drugs and help the industry transform from generic - drug - oriented to innovative drug R & D.
3. Mature Practical Framework: Five - link Approach Offers Implementable Transformation Paths
The mature framework system of AI empowering the pet industry covers the entire process from top - level architecture design, high - value scenario identification, process reengineering, data and knowledge engineering to model fine - tuning and deployment, providing industry enterprises with a directly referable practical path. AI technology has brought huge room for growth and development potential to the pet industry. However, this process requires in - depth collaboration between the mechanism cognition of industry experts and the innovation capabilities of technical teams to jointly explore business models and achieve win - win cooperation.
Amid the overall recovery of the investment and financing market, the hundreds - of - billions - scale “pet economy” has become a new blue ocean for capital competition. After two years of market downturn, the investment and financing market of the pet industry in 2025 has finally shown a clear growth trend.
We have successfully designed and produced over 100 products, successfully entering high-end markets such as the United States, Japan, Germany, France, and Russia.
